UA99014C2 - Methyl ester of n-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid exhibiting anti-inflammatory activity - Google Patents

Methyl ester of n-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid exhibiting anti-inflammatory activity

Info

Publication number
UA99014C2
UA99014C2 UAA201013361A UAA201013361A UA99014C2 UA 99014 C2 UA99014 C2 UA 99014C2 UA A201013361 A UAA201013361 A UA A201013361A UA A201013361 A UAA201013361 A UA A201013361A UA 99014 C2 UA99014 C2 UA 99014C2
Authority
UA
Ukraine
Prior art keywords
oxoindolinylidene
oxyacetyl
methyl ester
inflammatory activity
aminoacetic acid
Prior art date
Application number
UAA201013361A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Валерий Васильевич Болотов
Сергей Викторович Колиснык
Татьяна Ивановна Тюпка
Татьяна Александровна Лой
Анна Владимировна Мищенко
Original Assignee
Национальный Фармацевтический Университет
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Фармацевтический Университет filed Critical Национальный Фармацевтический Университет
Priority to UAA201013361A priority Critical patent/UA99014C2/en
Publication of UA99014C2 publication Critical patent/UA99014C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to chemico-pharmaceutical industry, in particular to individual bioactive chemical compounds that exhibit anti-inflammatory action at low toxicity and can be used as active substances in the composition of pharmaceutical preparations of different dosage forms.Disclosed is a methyl ester of N-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid of general formula:,exhibiting high anti-inflammatory activity.
UAA201013361A 2010-11-10 2010-11-10 Methyl ester of n-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid exhibiting anti-inflammatory activity UA99014C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201013361A UA99014C2 (en) 2010-11-10 2010-11-10 Methyl ester of n-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid exhibiting anti-inflammatory activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201013361A UA99014C2 (en) 2010-11-10 2010-11-10 Methyl ester of n-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid exhibiting anti-inflammatory activity

Publications (1)

Publication Number Publication Date
UA99014C2 true UA99014C2 (en) 2012-07-10

Family

ID=50848044

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201013361A UA99014C2 (en) 2010-11-10 2010-11-10 Methyl ester of n-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid exhibiting anti-inflammatory activity

Country Status (1)

Country Link
UA (1) UA99014C2 (en)

Similar Documents

Publication Publication Date Title
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
MX2015003653A (en) Benzoimidazole-carboxylic acid amide derivatives as apj receptor modulators.
CA2818925A1 (en) Inhibitors of the activity of complex iii of the mitochondrial electron transport chain and use thereof for treating diseases
MY167691A (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
WO2013066839A3 (en) Compounds and methods
WO2013066835A3 (en) Compounds and methods
MD4556C1 (en) Catechol O-methyltransferase activity inhibiting compounds
MX2011007192A (en) Bortezumib containing pharmaceutical composition.
EA201201050A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
MD20120050A2 (en) New agomelatine cocrystals, process for their preparation and pharmaceutical compositions containing them
MX2015003021A (en) Glycyrrhetinic acid derivatives with anti-inflammatory activity.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
TN2013000386A1 (en) Suspension type topical formulations comprising cyclic depsipeptide
UA96794C2 (en) Glucocorticoides, method of use thereof, treatment method and pharmaceutical formulation based thereon
TR201901792T4 (en) New (trimethoxyphenylamino) pyrimidinyl formulations.
MX2013013079A (en) Compositions comprising antibacterial agent and tazobactam.
MX2013002398A (en) Bace inhibitors for use in the treatment of diabetes.
UA99014C2 (en) Methyl ester of n-[(2-oxoindolinylidene-3)-2-oxyacetyl]aminoacetic acid exhibiting anti-inflammatory activity
EA201400365A1 (en) NEW THYRODUCT LACTS AS HIGHLY ACTIVE HDAC INHIBITORS AND THEIR APPLICATION AS MEDICINES
MX353693B (en) Crystalline phase of (3s.3s') 4,4'-disulfanediylbis(3-aminobutane 1 -sulfonic acid) with l-lysine.
WO2014045046A3 (en) Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
WO2011092655A3 (en) Mentha suaveolens essential oil and therapeutic activities thereof
UA100772C2 (en) N-[(1z)-2-[(2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-yl)amino]-2-oxo-1-(2-oxo-1,2-dihydro-3h-indole-3-ylidene)ethyl]benzamide exhibiting anabolic action
UA94866C2 (en) γ(R-BENZOLOXAMIDO)BUTANOIC ACIDS EXHIBITING DIURETIC, ANTI-INFLAMMATORY AND ANALGETIC ACTIVITY
GB201007446D0 (en) Composition for treatment of H.pylori